BPTRX
Price
$201.78
Change
-$1.16 (-0.57%)
Updated
Aug 15 closing price
Net Assets
7.43B
GFACX
Price
$72.53
Change
-$0.05 (-0.07%)
Updated
Aug 15 closing price
Net Assets
329.22B
Interact to see
Advertisement

BPTRX vs GFACX

Header iconBPTRX vs GFACX Comparison
Open Charts BPTRX vs GFACXBanner chart's image
Baron Partners Retail
Price$201.78
Change-$1.16 (-0.57%)
VolumeN/A
Net Assets7.43B
American Funds Growth Fund of Amer C
Price$72.53
Change-$0.05 (-0.07%)
VolumeN/A
Net Assets329.22B
BPTRX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BPTRX vs. GFACX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPTRX is a Hold and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 329B vs. BPTRX (7.43B). BPTRX (0.00) and GFACX (0.00) have matching dividends . BPTRX was incepted earlier than GFACX: BPTRX (22 years) vs GFACX (24 years). BPTRX (2.24) is less costly to investors than GFACX (1.36). GFACX is a more actively managed with annual turnover of: 25.00 vs. BPTRX (1.00). GFACX has a lower initial minimum investment than BPTRX: GFACX (250) vs BPTRX (2000). BPTRX annual gain was more profitable for investors over the last year : 33.83 vs. GFACX (12.43). BPTRX return over 5 years is better than : 90.83 vs. GFACX (34.56).
BPTRXGFACXBPTRX / GFACX
Total Expense Ratio2.241.36165%
Annual Report Gross Expense Ratio2.241.36165%
Fund Existence22 years24 years-
Gain YTD-4.10613.755-30%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets7.43B329B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year33.8312.43272%
Returns for 3 years18.8836.4152%
Returns for 5 years90.8334.56263%
Returns for 10 years417.7368.60609%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNGLX68.490.92
+1.36%
Janus Henderson Global Life Sciences D
AWSHX65.47-0.14
-0.21%
American Funds Washington Mutual A
BRWTX27.87-0.06
-0.21%
MFS Blended Research Growth Eq R3
NCEGX22.65-0.05
-0.22%
The North Country Large Cap Equity Fund
QCERX21.22-0.13
-0.61%
AQR Large Cap Multi-Style R6